AP Pharma's drug for chemotherapy-induced nausea denied approval

(Reuters) - U.S. health regulators denied approval to A.P. Pharma Inc's drug for treating chemotherapy-induced nausea and vomiting, and asked for additional analysis of existing late-stage data on the drug.

The U.S. Food and Drug Administration also asked for a study that can test the usability of the drug's syringe system.

The agency had earlier rejected the approval of the drug, APF530, in March 2010, citing concerns about its two-syringe administration system and deficiencies in the company's contract manufacturing facilities.

A.P. Pharma resubmitted its application in September last year after switching to a single-syringe system and conducting additional metabolism studies as required by the FDA.

(Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)

Source: http://news.yahoo.com/ap-pharmas-drug-chemotherapy-induced-nausea-denied-approval-113313673--finance.html

justin bieber Real Madrid Vs Manchester United Real Madrid Duck Dynasty sequestration Van Cliburn Sequester